Pharmaceutical News Pharmaceutical News Rss feed

  • Royalty Pharma takeover bid fails to find Elan ecceptance Royalty Pharma takeover bid fails to find Elan ecceptance

    DUBLIN/ WASHINGTON Ireland-based biotechnology firm Elan Thursday rejected Royalty Pharma's increased $6.4 billion takeover bid, shortly after the U.S. firm cut the acceptance bar for its latest offer to 50 percent plus one share. Royalty raised its hostile cash bid to $12.50 per share on Monday, from $11.25 previously, but made the new offer conditional on Elan shareholders rejecting, at a ...

  • Wockhardt shares plunge 20 pc on USFDA import alert Wockhardt shares plunge 20 pc on USFDA import alert

    MUMBAI - Shares of Wockhardt, one of the leading Indian pharmaceutical and biotechnology companies, witnessed a sharp fall of 20% to Rs. 1,315 ($23.61) on the Bombay Stock Exchange(BSE) on Thursday after the US FDA published an import alert on one of its three manufacturing facilities near Aurangabad. The import alert, 'detention without physical examination of drugs from firms which have ...

  • Former officer arrested in pharmacy shooting that killed 2 injured 2

    (WBIR- Bean Station, Tenn.) A former police officer is behind bars, accused of a shooting spree inside a local drugstore that left two men dead and two women injured. The shooting happened at the Down Home pharmacy in Bean Station around 11:15 am on Thursday. According to District Attorney General Jimmy Dunn, Jason Brian Holt, 37, was arrested shortly after the shooting. Investigators ...

  • News Summary JJ predicts surge of new medicines

    BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones.BIG IMPACT: Two experimental medicines could transform current treatments. One is an antidepressant that appears to work in just a day, instead of taking weeks. The other is a powerful painkiller that's not addictive.BIG REBOUND: ...

  • Agree To Buy Regeneron Pharmaceuticals At $165 Earn 9.8

    NASD: REGN ) shares, but tentative about paying the going market price of $256.05/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $165 strike, which has a bid at the time of this writing of $16.10. Collecting that bid as the premium represents a 9.8% return against ...


clear
London Weather
6°C Clear
Winds: From the West at 12 MPH
Sat
chancerain
16° 8°
Sun
partlycloudy
19° 9°
Mon
chancerain
16° 9°
Last Updated on May 24, 2:20 AM BST
Weather sourced from Weather Underground

Movie Review

GoldenEye

It's been six years since James Bond drew his Walter PB-K on the silver screen, and since that time there has been such a drastic change in the state of the world that one is forced to ask the question: "Is there room in the 90's for 007?" In today's post-Cold War politically correct environment, James Bond does not seem to have a comfortable niche. As the new female M tells him to his face, "Mr. ... ...

On Facebook

  • Bean Station police TBI investigating shooting at pharmacy

    It occurred at the Down Home Pharmacy, 1034 Main St., Bean Station, according to a Bean Station dispatcher, who did not have the time of the ...

  • Hobby Lobby birth control coverage up for federal appeal in Denver

    DENVER-In the most prominent challenge of its kind, Hobby Lobby Stores Inc. is asking a federal appeals court Thursday for an exemption from part of the federal health care law that requires it to offer employees health coverage that includes access to the morning-after pill. The Oklahoma City-based arts-and-crafts chain argues that businesses-not just the currently exempted religious ...

  • JJ Anticipates 10 Potential New Product Filings by 2017

    At a meeting today with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced they anticipate submitting more than 10 new product filings and more than 25 significant brand line extensions by ...

  • Groundbreaking anti-aging dietary supplement

    Jeunesse Global®, a network marketing company that dedicates its research to promoting healthy and youthful living, has produced the solution to one of the fundamental causes of cellular aging. Announcing a revolutionary development in anti-aging and science called FINITI™: a dietary supplement based on Nobel Prize winning research. To appreciate the importance of this ...

  • Cenix BioScience Debiopharm partner to develop novel therapeutic drug candidates

    Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, ...

More Pharmaceutical News